Helicobacter pylori therapy: Present and future

Cesare Hassan, V De Francesco, E Ierardi, A. Zullo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Helicobacter pylori (H. pylori) plays a crucial role in the pathogenesis of chronic active gastritis, peptic ulcer and gastric mucosa-associated lymphoid tissue-lymphoma, and is also involved in carcinogenesis of the stomach. H. pylori treatment still remains a challenge for physicians, since no current first-line therapy is able to cure the infection in all treated patients. Several factors may help in the eradication of therapy failure. We reviewed both bacterial and host factors involved in therapeutic management of the H. pylori infection. In addition, we evaluated data on the most successful therapy regimens - sequential and concomitant therapies - currently available for H. pylori eradication.
Lingua originaleEnglish
pagine (da-a)68-73
Numero di pagine6
RivistaWORLD JOURNAL OF GASTROINTESTINAL PHARMACOLOGY AND THERAPEUTICS
Volume3
DOI
Stato di pubblicazionePubblicato - 2012
Pubblicato esternamente

Keywords

  • Helicobacter pylori

Fingerprint

Entra nei temi di ricerca di 'Helicobacter pylori therapy: Present and future'. Insieme formano una fingerprint unica.

Cita questo